13 ms·
Subprime ‘unicorns’ that do not look a billion dollars
- tristanj 11y agoNon-paywall link: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=newssearch&cd=1&cad=rja&uact=8&ved=0CB4QqQIoADAAahUKEwi_18vgrsjIAhVC9mMKHdwwAmg&url=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F91063628-73f5-11e5-bdb1-e6e4767162cc.html&usg=AFQjCNEK2a0p_l8KdvG3wo-QO_IQLLnHzA&bvm=bv.105454873,d.cGc https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=newss...
- 7Figures2Commas 11y agoIt's kind of amusing that so many in Silicon Valley rail against Wall Street and "financial engineering" when the biggest "winners" of this tech boom are products of Wall Street and "financial engineering."
- adventured 11y agoIf we're talking only about start-ups that have gotten big during this boom, then you're very wrong. Uber, Xiaomi, Airbnb, Palantir, Snapchat, Didi Kuaidi, Flipkart, WhatsApp, Pinterest, and Dropbox are among the biggest winners so far. There's nothing Wall St or financial engineering about any of those. They're all legitimate businesses and or services that consumers blatantly want.
- 7Figures2Commas 11y agoLook at the investors in today's later rounds and the structures of the late-stage investments. This has nothing to do with consumer demand. There was consumer demand for subprime mortgages too. What we're talking about is where the late-stage money is coming from and how the valuations are being manufactured.
- lisaMM 11y ago100% percent sure! The only person that i can boldly say he can cure GENITAL HERPES VIRUS and any other kind of disease like CANCER,HIV/AIDS,LOW SPERM COUNT,MENOPAUSE DISEASE,ASEPSIS and can also solve any relationship problem, is this great herbalist man called DR.OKOJIE after i came in contact with him, thank you DR.OKOJIE for restoring my relationship back and CURE GENITAL HERPES out of my body. You can contact him via email: drokojiespellhome@gmail.com or call +2348051984310 or my email lisamcclean360@gmail.com
- lmm 11y agoUber and Airbnb are very much about financial engineering. Most of their edge comes from tax avoidance and regulatory avoidance.
- the_economist 11y agoUber and Airbnb are about consumer demand first and foremost.
- hkmurakami 11y agoCrucial note: This piece is written by Mike Mortiz of Sequoia. It appears to be in tandem with his recent appearance on Bloomberg News (http://www.bloomberg.com/news/articles/2015-10-17/sequoia-s-michael-moritz-q-a-venture-capital-is-high-risk-poker- http://www.bloomberg.com/news/articles/2015-10-17/sequoia-s-...)
- afarrell 11y ago> whose co-inventor committed suicide two years ago after telling his wife that it was not effective I feel... strange about reading this in an article when it is framed as evidence of anything. People's reasons for committing suicide are often complex and to mention that here seems... improper for reasons that I can't quite put my finger on.
- dsugarman 11y agoThe rate of suicide for founders is significant, it is not talked about enough.
- muzz 11y agoTrue, although he was not a founder
- scrollaway 11y agoI think it can be extended to "[the suicide rate amongst] people who give a huge part of their life onto a particular entity or product".
- throwaway13337 11y agoOr could it be more accurately "the suicide rate among people who wrap their self worth in their financial success".
- hkmurakami 11y agoI think SV is even more perverse because there are plenty of cases where people are chasing some nebulous definition of "success" that is not tied to financial success. If it's just financial success and you're a very sharp, bright person, be a quant trader at a prop trading firm or something similar.
- 11y ago
- pbreit 11y agoI don't know what to think of Theranos. On one hand, it is tackling a huge, important market and appears or appeared to have something legitimate. On the other, so many of its tactics seem designed more to increase valuation than successfully bring its technology to market. It's obscenely celebrity board completely devoid of any relevant experience. A ridiculous $9b valuation on a paltry (relatively) $400m raised. 100s of SKUs on its product list when it should be perfecting on a just a few. The incessant PR campaign around its founder. Giving Jim Cramer an exclusive? Refusing to participate in WSJ article. Spending a whole day with Harvard Fellows. Hiring slick crisis handlers. Threatening whistleblowers. I'm sure the incumbents wouldn't be that excited about a patent-protected entrant into the market but it doesn't seem like they are the ones mounting the attack. It either works or it doesn't right? And it'll be easy to figure that out. Can someone help me out?
- pen2l 11y agoIt is putting a lot of effort on PR. I went to https://www.theranos.com/ https://www.theranos.com/ for curiosity's sake, and was surprised to see that... well, the big center image has absolutely nothing to do with Theranos' technology, it's about "empowering women" (which is of course a laudable effort). My best guess is this is just 'fake it till you make it'. If they've got a 9 bil valuation, at least they can hire some smart folks who would otherwise be unhappy in proper academia. Maybe they're on to some technology and we will see that pivot soon.
- user_001 11y agoNot sure if you noticed, it's a carousel, the second slide mentions FDA clearance, the third mentions about the CLIA waiver.
- pen2l 11y agoThey got FDA clearance for JUST ONE test, the herpes one. It's not clear if it'll work for the many hundred others, as Theranos has suggested it can.
- birken 11y agoStartup L. Jackson has a good tweet about it: > 4/ You'd likely do better financially, on average, joining a Series A company, AND have more career upside. > Source: https://twitter.com/StartupLJackson/status/655154254722691072 https://twitter.com/StartupLJackson/status/65515425472269107... Why anybody would want to be an employee at a unicorn company is crazy to me, especially in the world of ultra-inflated valuations. If you join a huge public company you'll get liquid stock, at a real valuation, along with lots of salary and perks. The stock can't 10x, but companies will generally give you pretty large grants so if the stock goes up 20-50% you'll probably get a nice bump in your total compensation. If you want to join a startup, you are much better off joining a ~10-20MM one. You still get a salary, though maybe not as high as at a unicorn or public company. However, it is much easier for a ~10-20MM company to 10x in value than a 1B company, and if the smaller company does 10x you'd be a somebody at a ~100MM company rather than a nobody at a ~10B one.
- pbreit 11y agoYou're missing how startup equity works. At these multi-billion dollar companies, employee shares are priced way less than the valuations you are seeing published in the media. So you're almost guaranteed a nice payoff even if the company merely treads water.
- birken 11y agoA low strike price only matters if there is some eventual liquidity for the shares. For common stock this means IPO, acquisition or some other share buyback. Both IPOs and acquisitions generally don't apply to companies "treading water", only the extremely successful and growing ones manage to IPO (and even then it doesn't work out so great for shareholders: see YELP or BOX) or get acquired. Get acquired for less than your ultra-inflated valuation? Then the common shareholders get killed by liquidation preferences. And as for other share transactions, you'll need to find a buyer. Most savvy investors aren't going to be willing to pay huge valuation premiums for common stock. And if they aren't going to pay a premium, then you really haven't gained anything by issuing common shares at a lower strike price. So basically, common shares have lower strike prices because they are worth less.... It isn't some magic trick that automatically benefits employees.
- jimjimjam 11y agoSimple search on LinkedIn for Theranos: 139 current employees. 239 past employees. This company may technically be 10 years old, but lots of these churned employees listed Theranos as their last or second to last employer. That is a terrible ratio for a company of that size and age.
- LukeB_UK 11y agoYou're assuming that LinkedIn is a reliable source.
- Animats 11y agoNote that the author is the head of Sequoia Capital. "Sequoia, notably, also counts the highest number of private, billion-dollar ‘unicorns’ of any investor today and consistently finds itself in the largest tech startup exits."[1] If the head of the VC firm financing the largest number of "unicorns" says publicly that many of the "unicorns" are subprime, it's time to pay attention. [1] https://www.cbinsights.com/blog/sequoia-capital-teardown/ https://www.cbinsights.com/blog/sequoia-capital-teardown/
- benchtobedside 11y agoSerious question - what does he stand to gain from writing this piece?
- Animats 11y agoA defense to accusations of insider trading if they're dumping equity, perhaps.
- mcintyre1994 11y ago> Forget the fact that some of these valuations are illusory because the most recent investors have structured their investments as debt in all but name, meaning that they will stand to profit even if the company is worth far less. Can anyone recommend anything to read to get an insight into how one of these deals works? It's always seemed like liquidation preferences push a deal a fair way toward debt because (I think?) they get paid first and fully before anybody else. But that doesn't seem to be a recent thing at all.
- danielrhodes 11y agoA lot of these big rounds these unicorns are raising have crappy liquidation preferences, making the signal they give off of confidence in the company look much different.
- mcintyre1994 11y agoDon't Sequoia do this too though? They had 4x and 2.7x in Zappos rounds [0], they were in Stripe's reportedly >2x Series C [1]. Not trying to call out the author or Sequoia but this doesn't seem like anything new. Are the current deals even worse than 4x? [0] http://www.wac6.com/wac6/2009/08/sequoias-liquidation-preference-in-the-amazon-zappos-deal.html http://www.wac6.com/wac6/2009/08/sequoias-liquidation-prefer... [1] https://pando.com/2014/01/24/memo-to-stripe-winning-the-hearts-of-valley-startups-is-not-winning-payments/ https://pando.com/2014/01/24/memo-to-stripe-winning-the-hear...
- dawkins 11y ago"some of these valuations are illusory because the most recent investors have structured their investments as debt in all but name, meaning that they will stand to profit even if the company is worth far less" Can someone please explain this?
- toufka 11y agoNot my field - but it was talked about recently here. I'll do my best, but help me out here guys... Essentially, the money VC invests can be invested with a 'first-out' kind of option. So that were the company to fail, or sell for less than expected, that the very first people paid out of whatever pot of money is left would be the VCs. So imagine they say the company is worth $1B and a VC put in $200M. Company sells for a 'dismal' $210M. VC exits with their $200M back, and founders, team, other investors etc. all fight over the $10M that on paper seemed like $800M. As I recall, sometimes the investments are not just 'preferred' but are '2x preferred' or such things. In the end it distorts the incentives of the VC. The want the company to be worth a billion dollars, but if they say it, it's not true, the company crashes, and loses nearly everything, they in reality only lost the time-value of their investment, not actually any cash.
- sjg007 11y agoExtreme secrecy seems to be a bad thing in unicorns.
- mcintyre1994 11y agoSam Altman tweeted the same thing about YC applicants too: https://twitter.com/sama/status/654708548237066243 https://twitter.com/sama/status/654708548237066243
- aetherson 11y agoI want to like this article, but it seems pretty short on supporting evidence, besides Theranos in particular. Is there a reason to believe that Theranos is typical of the unicorns?
- ChuckMcM 11y agoI really like the label "sub-prime Unicorn". I really hope Theranos is not a fraud, I think the concept of rapid diagnostics with minimal source material is critical to scaling health care to the planet as a whole. But having watched people like Affymetrix and other "silicon-meets-organics" concepts go through the process of validation, I have always felt Theranos talks too much about how great they are going to be and how cool their founder is, and not enough about how they are going to get there. My observation is that companies that far ahead of the hype wave are more likely to flame out than ones that start very quietly and intercept the hype wave at or just after product introduction. Someone is going to figure this space (instant diagnostics through direct inspection) at some point. Still wondering if someone has.
- lisaMM 11y ago100% percent sure! The only person that i can boldly say he can cure GENITAL HERPES VIRUS and any other kind of disease like CANCER,HIV/AIDS,LOW SPERM COUNT,MENOPAUSE DISEASE,ASEPSIS and can also solve any relationship problem, is this great herbalist man called DR.OKOJIE after i came in contact with him, thank you DR.OKOJIE for restoring my relationship back and CURE GENITAL HERPES out of my body. You can contact him via email: drokojiespellhome@gmail.com or call +2348051984310 or my email lisamcclean360@gmail.com